EP2714036
Útskiptir (súbstitúeraðir) alífanar, sýklófanar, heterafanar, heterófanar, heteró-heterafanar og metallósenar sem nýtast við meðferð á HCV sýkingum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.5.2012EP published:
22.6.2016EP application number:
12793566.6
EP translation filed:
25.7.2016Grant published:
15.8.2016EPO information:
European Patent Register
Max expiry date:
28.5.2032Expiry date:
28.5.2019
Title:
SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS
Timeline
Today
29.5.2012EP application
22.6.2016EP Publication
25.7.2016Translation submitted
15.8.2016Registration published
28.5.2019Expires
Owner
Name:
Achillion Pharmaceuticals, Inc.Address:
300 George Street, 06511, New Haven, CT, US
Inventor
Name:
WILES, Jason AllanAddress:
Hamden, CT, US
Name:
WANG, QiupingAddress:
Bethany, CT, US
Name:
HASHIMOTO, AkihiroAddress:
Branford, CT, US
Name:
PAIS, GodwinAddress:
Hamden, CT, US
Name:
CHEN, DaweiAddress:
Middletown, CT, US
Name:
WANG, XiangzhuAddress:
Madison CT, US
Name:
GADHACHANDA, VenkatAddress:
Hamden, CT, US
Name:
PHADKE, AvinashAddress:
Branford, CT, US
Name:
DESHPANDE, MilindAddress:
Madison, CT, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201161490881 PDate:
27.5.2011Country:
US
Number:
201161504905 PDate:
6.7.2011Country:
US
Number:
201161567216 PDate:
6.12.2011Country:
US
Classification
Categories:
C07F 17/02, C07D 401/14, C07D 403/14, C07D 413/14, C07D 417/14, C07D 471/08, C07D 471/14, C07D 491/10, C07D 519/00, A61K 31/4178, A61K 31/4164, A61P 31/00, A61P 31/12
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 10.4.2017
Expires: 28.5.2018
Payer: Árnason Faktor
Number: 7
Paid: 14.5.2018
Expires: 28.5.2019
Payer: Árnason Faktor